Sarah Sneden's Colleagues at Centers for Respiratory Health
Sarah Sneden's Contact Details
N/A
Nashville Metropolitan Area
Centers for Respiratory Health
Sarah Sneden's Company Details
Center For Respiratory Health is a recognized leader producing real results and dedicated to providing cellular therapy for individuals with chronic lung disorders. We offer an overall wellness approach to your health and provide our patients with a more effective way to address chronic inflammatory lung conditions, such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, chronic bronchitis, emphysema, and interstitial lung disease. We are improving lives and helping patients Breathe Easier.*The goal of any treatment for chronic lung disorders is to help with the management of symptoms and potentially:•Reduce inflammation•Improve your ability to breathe easier•Improve overall lung functionAs part of a recent peer reviewed publication, data indicated 83% of COPD patients reported an improvement in their quality of life at 3 months after treatment.**In addition, 67% of patients with COPD using our innovative treatment experienced an improvement and/or no decline in their FEV1 at 3 months after treatment.**You can continue to use your current pulmonology care and add our innovative treatment to potentially improve your overall lung health.It is time for you to take your life back from chronic lung disorders. Call us today and learn more about what our innovative therapy has the potential to do for you. Our dedicated team of Patient Care Specialist and Board-Certified Medical Providers is standing by to answer all your question.Disclaimer:** Rubio MM, et al. Platelet Rich Plasma- Platelet Concentrate Therapy in COPD: An Observational Cohort Study. J Reg Med Biol Res 2021;2(2):1-10.*Each patient is different, and results may vary.These statements have not been evaluated by the Food and Drug Administration. This information is not intended to suggest diagnosis, treatment, cure or prevention of any disease. Our company operates in compliance with CFR Title 21 Part 1271.15 (b) Regulation.